339 related articles for article (PubMed ID: 16412695)
1. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant adeno-associated virus for skeletal gene therapy.
Dai J; Rabie AB
Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
Blankinship MJ; Gregorevic P; Chamberlain JS
Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer by adeno-associated virus vectors into the central nervous system.
Xiao X; Li J; McCown TJ; Samulski RJ
Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
6. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
Rolling F
Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
[TBL] [Abstract][Full Text] [Related]
7. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.
Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC
Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187
[TBL] [Abstract][Full Text] [Related]
8. Current issues in adeno-associated viral vector production.
Merten OW; Gény-Fiamma C; Douar AM
Gene Ther; 2005 Oct; 12 Suppl 1():S51-61. PubMed ID: 16231056
[TBL] [Abstract][Full Text] [Related]
9. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
Hallek M; Wendtner CM
Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality.
Muramatsu S; Wang L; Ikeguchi K; Fujimoto K; Nakano I; Ozawa K
J Neurol; 2002 Sep; 249 Suppl 2():II36-40. PubMed ID: 12375062
[TBL] [Abstract][Full Text] [Related]
12. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
14. Inducible long-term gene expression in brain with adeno-associated virus gene transfer.
Haberman RP; McCown TJ; Samulski RJ
Gene Ther; 1998 Dec; 5(12):1604-11. PubMed ID: 10023439
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated viral vectors: background and technical aspects.
Snoeck HW; Tao W; Klotman ME
Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
Grieger JC; Samulski RJ
Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.
Le Bec C; Douar AM
Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010
[TBL] [Abstract][Full Text] [Related]
19. AAV-mediated gene therapy for retinal disorders: from mouse to man.
Buch PK; Bainbridge JW; Ali RR
Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus-mediated gene delivery.
Snyder RO
J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
